StockNews.AI
HIMS
StockNews.AI
29 days

Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 25, 2025 to Discuss Your Rights - HIMS

1. Hims faces a class action lawsuit for misleading safety claims. 2. Allegations include deceptive promotion of illegitimate Wegovy® versions. 3. Possible termination of partnership with Novo Nordisk is a risk. 4. Class action registration deadline is August 25, 2025. 5. Shareholders can participate without obligation by registering.

5m saved
Insight
Article

FAQ

Why Bearish?

Legal challenges can lead to reputational harm and potential financial liabilities. Historically, similar lawsuits have negatively impacted stock prices of affected companies.

How important is it?

The allegations could deter investors and affect HIMS's collaborations, crucial for their business. The ongoing litigation poses risks that may significantly impact stock performance.

Why Short Term?

The lawsuit's immediate implications on investor confidence can influence HIMS's stock in the near term. Following legal precedents, stock reactions often occur rapidly after negative news.

Related Companies

NVO
, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=157181&from=4 CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;" (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. DEADLINE: August 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=157181&from=4 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HIMS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 25, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: [email protected]Phone: (646) 453-8903 SOURCE The Gross Law Firm WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News